Khosla

 Rubedo Life Sciences Closes $12M Seed Financing Led by Khosla Ventures

Retrieved on: 
Thursday, December 3, 2020
Data management, Other Science, Technology, Research, General Health, VoIP, Other Health, Pharmaceutical, Oncology, Semiconductor, Genetics, Security, Clinical trials, Nanotechnology, Other Technology, Biotechnology, Telecommunications, Software, Health, Science, Life sciences, Businesspeople, Biotechnology, Vinod Khosla, Khosla Ventures, Khosla, Biopharmaceutical

Rubedo Life Sciences , a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the closing of a $12M Seed financing round.

Key Points: 
  • Rubedo Life Sciences , a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the closing of a $12M Seed financing round.
  • The round was led by Khosla Ventures, with participation from Longevity Fund, Refactor Capital, Shanda and additional investors.
  • Rubedo has made remarkable progress and this seed investment will accelerate development of their clinical pipeline, said Vinod Khosla, founder of Khosla Ventures.
  • Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases.

Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures

Retrieved on: 
Thursday, October 29, 2020
Research, Surgery, Medical devices, Clinical trials, Biotechnology, Health, Pharmaceutical, Science, Oncology, Businesspeople, Khosla Ventures, Corporate governance, Vinod Khosla, Khosla, Advanced Chemotherapy Technologies, Khosla Ventures

Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a $5.5 million Series A investment round led by Khosla Ventures.

Key Points: 
  • Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a $5.5 million Series A investment round led by Khosla Ventures.
  • ACT has made remarkable progress leveraging their seed investment and NIH grants to advance their first product, ACT-IOP-003, into the clinic, said Vinod Khosla, founder of Khosla Ventures.
  • We are excited to have the support of such an outstanding Venture Capital firm in Khosla Ventures, said Tony Voiers, CEO of Advanced Chemotherapy Technologies.
  • Advanced Chemotherapy Technologies, Inc. is a privately owned, clinical-stage company developing novel approaches to local drug delivery.

Synopsys to Host Panel on AI for Chip Design at AI Hardware Summit 2020

Retrieved on: 
Monday, September 28, 2020
Articles, Businesspeople, Science and technology, Computational neuroscience, Khosla Ventures, Artificial intelligence, Vinod Khosla, Khosla, Synopsys

When:Tuesday, September 29 at 11 a.m. Pacific

Key Points: 
  • When:Tuesday, September 29 at 11 a.m. Pacific
    Panel Details: Is AI the Next Killer App in Silicon Design?
  • In addition to hosting the panel, Synopsys will also host a roundtable discussion on September 30 at 10:15 a.m. Pacific, led by Stelios Diamantidis, director of AI Products & Strategy, to answer questions and share more technical insights on the topic of AI in chip design.
  • The AI Hardware Summit is the predominant leadership forum for AI hardware, providing unique perspectives from industry luminaries such as Turing Award Winner David Patterson from Google, and venture capital pathfinder and computer hardware industry veteran, Vinod Khosla, the founder of Khosla Ventures.
  • Attendees will hear about recent product launches and deep-dives from C-level executives in the AI hardware industry, covering topics from AI and machine learning to model standardization and interoperability.

Kernel Raises $53M from General Catalyst, Khosla Ventures, Eldridge

Retrieved on: 
Thursday, July 9, 2020
Biotechnology, Hardware, Health, Mental health, Medical devices, Data management, Technology, Mobile, Wireless, Operating systems, Businesspeople, System software, Vinod Khosla, Khosla Ventures, Kernel, Khosla, Bryan Johnson, Linux kernel, Vinod

Kernel announced today the close of a $53M Series C round of venture financing, led by General Catalyst, with participation from Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Kernel founder and CEO, Bryan Johnson.

Key Points: 
  • Kernel announced today the close of a $53M Series C round of venture financing, led by General Catalyst, with participation from Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Kernel founder and CEO, Bryan Johnson.
  • General Catalysts Quentin Clark also joins Kernels Board of Directors with this transaction.
  • The brain and mind are next, said Bryan Johnson, CEO and Founder of Kernel.
  • "Kernel's technology now enables access to high-fidelity neural data at scale," said Vinod Khosla, Founder of Khosla Ventures.

HeartVista Closes $8.65M Series A Financing Led by Khosla Ventures

Retrieved on: 
Tuesday, April 28, 2020
Science, Other Science, Research, General Health, Health, Data management, Technology, Other Technology, Businesspeople, Khosla Ventures, Vinod Khosla, Khosla, Economy of the United States, One-Click MRI Solution, HeartVista

The round was led by Khosla Ventures, Jeff Rothschild, Leslie Ventures, Open Field Capital, and additional investors.

Key Points: 
  • The round was led by Khosla Ventures, Jeff Rothschild, Leslie Ventures, Open Field Capital, and additional investors.
  • Were excited to attract such a strong group of investors, led by Khosla Ventures, said Itamar Kandel, CEO of HeartVista.
  • We are big believers in AI when applied to imaging and HeartVista is a thought leader in this area, said Vinod Khosla, Founder of Khosla Ventures.
  • HeartVista is funded by Khosla Ventures, and the National Institute of Healths Small Business Innovation Research program.

AliveCor Appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board

Retrieved on: 
Wednesday, July 24, 2019
Khosla Ventures, Vinod Khosla, Businesspeople, Alivecor, Kleiner Perkins, Vinod, Khosla, Economy of the United States, Abani, Articles

MOUNTAIN VIEW, Calif., July 24,2019 /PRNewswire/ -- AliveCor , the leader in FDA-cleared consumer electrocardiogram technology, today announced the appointment of Priya Abani as Chief Executive Officer.

Key Points: 
  • MOUNTAIN VIEW, Calif., July 24,2019 /PRNewswire/ -- AliveCor , the leader in FDA-cleared consumer electrocardiogram technology, today announced the appointment of Priya Abani as Chief Executive Officer.
  • Simultaneously, AliveCor announced that Vinod Khosla has been elected chairman of its board of directors.
  • Khosla founded Khosla Ventures in 2004 and was formerly a General Partner at Kleiner Perkins and founder of Sun Microsystems.
  • Ira Bahr, who previously served as interim Chief Executive, will become Chief Operating Officer and report to Abani.

Why Everybody Should HUG Their Favorite Billionaire Next Door

Retrieved on: 
Wednesday, March 20, 2019
Businesspeople, Economy of the United States, Vinod Khosla, Khosla, Economy, Donald Trump, Billionaire

As venture capitalist Vinod Khosla recently said, "Here's the problem with those (high taxes)--there is international mobility."

Key Points: 
  • As venture capitalist Vinod Khosla recently said, "Here's the problem with those (high taxes)--there is international mobility."
  • By loving, appreciating, and emulating their favorite billionaires.
  • Love- thank billionaires for inspiring others, encourage them to keep providing massive value to the marketplace, and give them a hug when interacting with them (a side hug in case they're germ-conscious like Donald Trump).
  • There's never been a better time than now to massively improve the world, and maybe even become a billionaire yourself in the process."